YAP1 and meningioma: Despite current evidence suggesting that Hippo pathway YAP fusion events may act as alternative drivers of meningioma incidence than NF2, further research is needed to understand the oncogenic functions of the Hippo pathway in meningiomas in order to exploit these functions in diagnosis and the discovery of specific therapeutic targets for treatment of meningiomas and other tumors.